INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

GRCEGrace Therapeutics, Inc.

CIK 0001444192

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells5 / 0
Max Insider Score29
Connections2with evidence

GRCE · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
25
OM
Opaleye Management Inc.10% Owner
GRCEGrace Therapeutics, Inc.
Open-market purchase
BUY$41K
21.4K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Opaleye Management Inc.10% Owner · Sep 23, 2026
28
OM
Opaleye Management Inc.10% Owner
GRCEGrace Therapeutics, Inc.
Open-market purchase
BUY
$117K
66.4K sh
Oct 26, 2026
Oct 26, 2026
traded Oct 26, 2026
+0d
SEC FORM 4

Evidence

25
OM
Opaleye Management Inc.10% Owner
GRCEGrace Therapeutics, Inc.
Open-market purchase
BUY$8,001
4,256 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

29
OM
Opaleye Management Inc.10% Owner
GRCEGrace Therapeutics, Inc.
Open-market purchase
BUY$21K
9,771 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

25
OM
Opaleye Management Inc.10% Owner
GRCEGrace Therapeutics, Inc.
Open-market purchase
BUY$11K
5,318 sh
Sep 23, 2026Sep 23, 2026
traded Sep 23, 2026
+0dSEC FORM 4

Evidence